Aimmune Therapeutics

191 articles about Aimmune Therapeutics

• 4 Biotech Stocks That Could Triple In Value This Year

  8/4/2016

• Aimmune To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference

  7/5/2016

• Bay Area's Aimmune Taps Former Alvine Pharma-Sunesis Exec as New CMO

  6/21/2016

• Aimmune Announces Phase II Extended Maintenance Data Supporting Safety And Tolerability Profile Of AR101 For Peanut Allergy

  6/13/2016

• AimmuneAnnounces Late-Breaker Presentation At The European Academy Of Allergy And Clinical Immunology (EAACI) Congress 2016

  6/7/2016

• Aimmune To Present At Upcoming June Investor Conferences

  5/31/2016

• Aimmune Announces First Quarter 2016 Financial Results And Provides Corporate Update

  5/17/2016

• Aimmune To Present At The Bank of America Merrill Lynch 2016 Health Care Conference

  5/4/2016

• Aimmune Presents Data On Biomarkers And Potential To Predict Response To Peanut Allergy Treatment With AR101

  4/11/2016

• Aimmune Appoints Douglas Sheehy As General Counsel And Secretary

  4/5/2016

• Aimmune Announces Phase 2 Follow-On Study Of AR101 For The Treatment Of Peanut Allergy Demonstrated Increased Desensitization And Improved Tolerability With Low-Dose Maintenance

  3/7/2016

• Aimmune Announces Fourth Quarter And Full Year 2015 Financial Results And Provides Corporate Update

  3/4/2016

• Aimmune To Participate In Two Upcoming Investor Conferences In March

  3/1/2016

• Aimmune To Announce Fourth Quarter And Full Year 2015 Financial Results On Thursday, March 3, 2016

  2/25/2016

• Aimmune Announces Presentation At The 2016 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  2/10/2016

• Aimmune To Present At The 18th Annual BIO CEO & Investor Conference

  2/1/2016

• Aimmune Enrolls First Patient In Phase III PALISADE Trial Of AR101 For The Treatment Of Peanut Allergy

  1/11/2016

• Aimmune To Present At The 34th Annual J.P. Morgan Healthcare Conference

  1/6/2016

• Aimmune Appoints Jeffrey H. Knapp As Chief Operating Officer

  12/17/2015

• Aimmune To Present At The Piper Jaffray 27th Annual Healthcare Investor Conference

  11/16/2015